DexCom Inc
Close on Nov 19, 2026Market cap $29.91BP/E 31.6Yield –
DexCom Total Allocated Share-Based Compensation Expense by Quarter
Total Allocated Share-Based Compensation Expense ($M)
DexCom Total Allocated Share-Based Compensation Expense: $36.8M in Q3 2026, down 18.4% from a year earlier.
Where the Q3 2026 figure comes from
Source: 10-Q (FY2026Q3, filed 2026-10-29) ↗
Reported in Form 10-K & Form 10-Q Footnotes (XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total Allocated Share-Based Compensation Expense
Cite this data
StockData. (2026). DexCom Total Allocated Share-Based Compensation Expense ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/sbc-alloc-total
See every metric in the DexCom KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?